KIA
Kopp Investment Advisors Portfolio holdings
AUM
$54.4M
This Quarter Return
+8.44%
1 Year Return
+14.33%
3 Year Return
+109.21%
5 Year Return
+340.79%
10 Year Return
–
AUM
$256M
AUM Growth
–
Cap. Flow
+$256M
Cap. Flow
% of AUM
100%
Top 10 Holdings %
Top 10 Hldgs %
46.55%
Holding
93
New
93
Increased
–
Reduced
–
Closed
–
Top Buys
| 1 |
FNSR
Finisar Corp
FNSR
|
$18.9M |
| 2 |
ARRY
Array Biopharma Inc
ARRY
|
$16.3M |
| 3 |
SRGA
Surgalign Holdings, Inc. Common Stock
SRGA
|
$15.3M |
| 4 |
AKRX
Akorn, Inc.
AKRX
|
$12.1M |
| 5 |
TEAR
TearLab Corporation
TEAR
|
$11M |
Top Sells
No sells this quarter
Sector Composition
| 1 | Healthcare | 41.94% |
| 2 | Technology | 24.85% |
| 3 | Consumer Staples | 4.53% |
| 4 | Financials | 1.49% |
| 5 | Consumer Discretionary | 1.03% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
|
IDTI
26
DELISTED
Integrated Device Technology I
IDTI
| $2.29M | 0.9% | +288,682 | New | +$2.29M |
|
|
VVUS
27
DELISTED
Vivus Inc
VVUS
| $2.29M | 0.89% | +181,935 | New | +$2.29M |
|
28
AngioDynamics
ANGO
$417M
| $2.13M | 0.83% | +189,116 | New | +$2.13M |
|
29
Celldex Therapeutics
CLDX
$1.47B
| $2.11M | 0.82% | +134,915 | New | +$2.11M |
|
|
ACCL
30
DELISTED
ACCELRYS INC
ACCL
| $2.06M | 0.81% | +245,645 | New | +$2.06M |
|
31
Ligand Pharmaceuticals
LGND
$3.15B
| $1.85M | 0.72% | +49,379 | New | +$1.85M |
|
|
CTCT
32
DELISTED
CONSTANT CONTACT, INC COM
CTCT
| $1.83M | 0.72% | +114,021 | New | +$1.83M |
|
|
NVDQ
33
DELISTED
Novadaq Technologies Inc.
NVDQ
| $1.83M | 0.71% | +135,682 | New | +$1.83M |
|
|
IL
34
DELISTED
IntraLinks Holdings Inc.
IL
| $1.69M | 0.66% | +232,199 | New | +$1.69M |
|
|
TQNT
35
DELISTED
TRIQUINT SEMICONDUCTOR INC
TQNT
| $1.38M | 0.54% | +199,593 | New | +$1.38M |
|
|
CPHD
36
DELISTED
Cepheid Inc
CPHD
| $1.36M | 0.53% | +39,368 | New | +$1.36M |
|
37
Regeneron Pharmaceuticals
REGN
$61.5B
| $1.34M | 0.52% | +5,963 | New | +$1.34M |
|
|
THOR
38
DELISTED
THORATEC CORPORATION
THOR
| $1.33M | 0.52% | +42,495 | New | +$1.33M |
|
|
LCI
39
DELISTED
Lannett Company, Inc.
LCI
| $1.28M | 0.5% | +107,660 | New | +$1.28M |
|
40
HealthStream
HSTM
$832M
| $1.25M | 0.49% | +49,378 | New | +$1.25M |
|
|
OREX
41
DELISTED
Orexigen Therapeutics, Inc.
OREX
| $1.25M | 0.49% | +213,752 | New | +$1.25M |
|
42
Cytokinetics
CYTK
$4.23B
| $1.24M | 0.49% | +107,343 | New | +$1.24M |
|
|
ROCM
43
DELISTED
ROCHESTER MEDICAL CORP
ROCM
| $1.23M | 0.48% | +83,268 | New | +$1.23M |
|
44
Alkermes
ALKS
$4.78B
| $1.21M | 0.47% | +42,034 | New | +$1.21M |
|
45
Johnson & Johnson
JNJ
$427B
| $1.08M | 0.42% | +12,563 | New | +$1.08M |
|
46
Neogen
NEOG
$1.25B
| $1.07M | 0.42% | +19,310 | New | +$1.07M |
|
|
RKUS
47
DELISTED
RUCKUS WIRELESS INC COM STK (DE)
RKUS
| $1.01M | 0.39% | +78,597 | New | +$1.01M |
|
|
GNMK
48
DELISTED
GenMark Diagnostics, Inc
GNMK
| $997K | 0.39% | +96,384 | New | +$997K |
|
49
Blackrock
BLK
$175B
| $981K | 0.38% | +3,820 | New | +$981K |
|
50
Wells Fargo
WFC
$263B
| $980K | 0.38% | +23,748 | New | +$980K |
|